Does ALIROCUMAB Cause Dyspnoea exertional? 133 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Dyspnoea exertional have been filed in association with ALIROCUMAB (Praluent). This represents 0.6% of all adverse event reports for ALIROCUMAB.
133
Reports of Dyspnoea exertional with ALIROCUMAB
0.6%
of all ALIROCUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Dyspnoea exertional From ALIROCUMAB?
Of the 133 reports, 6 (4.5%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which ALIROCUMAB Alternatives Have Lower Dyspnoea exertional Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN